title: Local Inflammation Alters MMP-2 and MMP-9 Gelatinase Expression Associated with the Severity of Nifedipine-Induced Gingival Overgrowth: a Rat Model Study.
abstract: Nifedipine-induced gingival overgrowth (NIGO) is characterized by cell proliferation and extracellular matrix (ECM) component accumulation in gingival connective tissues, with varying degrees of inflammation and fibrosis. Impaired collagen and ECM homeostasis may be among the underlying molecular mechanisms that lead to the fibrotic changes that occur in drug-induced gingival overgrowth (DIGO). Because matrix metalloproteinases (MMPs) play vital roles in regulating collagen and ECM metabolism, many studies have been performed to reveal the relationship between MMPs and DIGO. It is thought that the gelatinases MMP-2 and MMP-9, both type IV collagenases, are involved in the development of tissue inflammation and organ fibrosis. However, the few studies regarding gelatinase expression in DIGO are controversial. Recent studies have demonstrated the inhibitory effect of cyclosporine A (CsA) on gelatinase expression and/or activity; however, similar changes have yet to be detected in Nif-treated gingival tissues. In this study, we verified that Nif treatment could lead to gingival overgrowth in rats and that gingival inflammation played a pro-proliferative role in NIGO development. Additionally, we examined the temporal expression of gelatinases on days 0, 7, 14, 21, 30, and 40 during NIGO development. The aim was to investigate whether MMP-2 and MMP-9 played significant roles in regulating NIGO development and progression. MMP-2 gene expression was not altered by Nif treatment alone but was significantly inhibited by Nif treatment for 30 days in the presence of local inflammation. However, no significant alterations in MMP-2 protein expression were detected in the Nif-treated gingival tissue, regardless of the presence or absence of local inflammation. Moreover, Nif treatment could lead to transient and significant increases in MMP-9 gene and protein expression levels in the presence of local inflammation. In particular, active MMP-9 expression increased significantly in the gingival tissue that received the combined effect of Nif and ligation treatment; besides, a temporal, but not significant, change was also observed in the gingival tissue that received Nif treatment alone. Taken together, these results provided evidence that temporal changes in MMP-2 and MMP-9 expression occurred during NIGO development. Nif treatment accompanied by local inflammation regulated MMP-2 and MMP-9 expression, primarily MMP-9, which was most likely associated with NIGO severity. Thus, MMP-9 is a potential contributing factor in the process of NIGO development.
authors: Department of Conservative Dentistry, Laboratory of Oral Biomedical Science and Translational Medicine, School of Stomatology, Tongji University, Shanghai, 200072, People's Republic of China.
authors: Wu-Li
authors: WL
authors: Li
authors: Cheng-Hai
authors: CH
authors: Wu
authors: Jun
authors: J
authors: Yang
authors: Min
authors: M
authors: Tang
authors: Long-Jie
authors: LJ
authors: Chen
authors: Shou-Liang
authors: SL
authors: Zhao
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D004195:Disease Models, Animal; D015971:Gene Expression Regulation, Enzymologic; D019214:Gingival Overgrowth / Q000139:chemically induced / Q000201:enzymology* / Q000473:pathology; D007249:Inflammation / Q000139:chemically induced / Q000201:enzymology / Q000473:pathology; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000096:biosynthesis*; D020780:Matrix Metalloproteinase 9 / Q000096:biosynthesis*; D009543:Nifedipine / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012720:Severity of Illness Index
chemical_list: D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D009543:Nifedipine
references: Spec Care Dentist. 1991 May-Jun;11(3):107-9
references: 1887359
references: J Periodontol. 1996 May;67(5):463-71
references: 8724703
references: J Periodontal Res. 2012 Aug;47(4):431-8
references: 22321150
references: J Inflamm (Lond). 2010 Sep 15;7:48
references: 20843335
references: J Periodontol. 1987 Sep;58(9):639-42
references: 3477631
references: J Periodontal Res. 1989 May;24(3):207-13
references: 2550604
references: J Periodontol. 1997 Jan;68(1):92-8
references: 9029457
references: J Periodontal Res. 2009 Jun;44(3):338-47
references: 19210333
references: J Periodontol. 2001 Oct;72(10):1398-406
references: 11699482
references: Cell Biol Toxicol. 2002;18(1):51-61
references: 11991086
references: J Hum Hypertens. 2014 Jan;28(1):10-4
references: 23739159
references: J Periodontal Res. 2010 Aug;45(4):451-7
references: 20337887
references: J Periodontal Res. 2006 Aug;41(4):266-72
references: 16827719
references: Nat Rev Mol Cell Biol. 2007 Mar;8(3):221-33
references: 17318226
references: J Biol Chem. 2002 Jan 18;277(3):2065-72
references: 11689563
references: J Periodontol. 2015 Jan;86(1):82-90
references: 25119556
references: Cell Tissue Res. 2006 Sep;325(3):513-22
references: 16670920
references: Inflammation. 2008 Dec;31(6):399-407
references: 18982435
references: J Periodontol. 2013 May;84(5):634-40
references: 22934840
references: Arch Oral Biol. 2010 Jul;55(7):523-9
references: 20538258
references: Mediators Inflamm. 2013;2013:639468
references: 23690667
references: J Periodontol. 1999 Sep;70(9):967-72
references: 10505798
references: Lancet. 1987 Sep 26;2(8561):739
references: 2888958
references: J Periodontal Res. 2008 Oct;43(5):570-7
references: 18624953
references: Lab Invest. 1994 Feb;70(2):176-82
references: 8139259
references: J Periodontol. 1998 Jul;69(7):765-71
references: 9706853
references: J Periodontol. 2008 Jan;79(1):114-22
references: 18166100
references: J Periodontol. 2008 Jan;79(1):166-73
references: 18166107
references: Histol Histopathol. 2009 Feb;24(2):157-66
references: 19085832
references: J Periodontal Res. 1993 Nov;28(6 Pt 1):396-403
references: 8254456
references: Int J Neurosci. 2014 Oct;124(10):707-16
references: 24304146
references: Biochim Biophys Acta. 2014 Aug;1840(8):2571-80
references: 24631662
references: J Dent Res. 2011 Jul;90(7):887-93
references: 21483030
references: Pathol Int. 1998 Dec;48(12):954-63
references: 9952339
references: J Clin Periodontol. 1992 May;19(5):311-4
references: 1517474
references: ISRN Dent. 2011;2011:497850
references: 21991476
references: Mediators Inflamm. 2013;2013:275172
references: 23431239
references: J Periodontal Res. 2004 Apr;39(2):87-92
references: 15009515
references: J Clin Periodontol. 2000 Apr;27(4):217-23
references: 10783833
references: J Periodontol. 2001 May;72(5):605-11
references: 11394395
references: J Periodontol. 2003 Feb;74(2):188-95
references: 12666707
references: Am J Pathol. 2010 Jul;177(1):208-18
references: 20489142
references: Aust Dent J. 2007 Dec;52(4):295-9
references: 18265685
references: Int J Periodontics Restorative Dent. 1996 Jun;16(3):278-91
references: 9084313
references: J Endod. 2005 Dec;31(12):860-2
references: 16306818
references: Oral Dis. 2006 Mar;12(2):156-62
references: 16476037
references: Int J Cardiol. 1984 Feb;5(2):195-206
references: 6607894